engleski

Immune reactivity of renal transplant recipients during the first six-weeks posttransplant follow-up

The purpose of our study was to estimate the immune reactivity of renal allograft recipients receiving the anti-CD25 monoclonal antibody daclizumab, as part of the standard immunosuppressive protocol. The results of our study showed that cell cycle analysis represents a valuable tool for the immunological follow-up of renal transplant recipients and the optimization of immunosuppressive treatment.

Daclizumab; Flow Cytometry; Immunosuppression; Lymphocyte Cell Cycle; Kidney Transplantation

nije evidentirano